Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q1 2023 Earnings

8MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-0.68

-0.65

-0.61

-0.58

Details

Expected EPS

-0.68

Actual EPS

-0.58

Surprise EPS

0.1

Surprise Percent

+14.71%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.58 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.